These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22641473)

  • 1. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.
    Marichal-Gallardo PA; Alvarez MM
    Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream processing of monoclonal antibodies--application of platform approaches.
    Shukla AA; Hubbard B; Tressel T; Guhan S; Low D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):28-39. PubMed ID: 17046339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
    Dizon-Maspat J; Bourret J; D'Agostini A; Li F
    Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic comparison of diagnostic antibody production in perfusion stirred tank and in hollow fiber bioreactor processes.
    Vermasvuori R; Hurme M
    Biotechnol Prog; 2011; 27(6):1588-98. PubMed ID: 21954092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.
    Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G
    Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody capture and viral clearance by cation exchange chromatography.
    Miesegaes GR; Lute S; Strauss DM; Read EK; Venkiteshwaran A; Kreuzman A; Shah R; Shamlou P; Chen D; Brorson K
    Biotechnol Bioeng; 2012 Aug; 109(8):2048-58. PubMed ID: 22488719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification.
    Borlido L; Moura L; Azevedo AM; Roque AC; Aires-Barros MR; Farinha JP
    Biotechnol J; 2013 Jun; 8(6):709-17. PubMed ID: 23420794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion exchange resins for the purification of monoclonal antibodies from animal cell culture.
    Graf H; Rabaud JN; Egly JM
    Bioseparation; 1994 Feb; 4(1):7-20. PubMed ID: 7764588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.
    Shamashkin M; Godavarti R; Iskra T; Coffman J
    Biotechnol Bioeng; 2013 Oct; 110(10):2655-63. PubMed ID: 23633385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to chromatographic separations.
    Thömmes J; Etzel M
    Biotechnol Prog; 2007; 23(1):42-5. PubMed ID: 17269668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges.
    Somasundaram B; Pleitt K; Shave E; Baker K; Lua LHL
    Biotechnol Bioeng; 2018 Dec; 115(12):2893-2907. PubMed ID: 30080940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process and economic evaluation for monoclonal antibody purification using a membrane-only process.
    Varadaraju H; Schneiderman S; Zhang L; Fong H; Menkhaus TJ
    Biotechnol Prog; 2011; 27(5):1297-305. PubMed ID: 21618725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process-scale purification from cell culture supernatants: monoclonal antibodies.
    Ostlund C; Borwell P; Malm B
    Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in large-scale production of monoclonal antibodies and related proteins.
    Shukla AA; Thömmes J
    Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.